While specific longitudinal data on PKD2 truncating variants are limited, PKD2 mutations in general are associated with milder ADPKD, where midlife onset of end-stage renal disease is delayed 10–15 years compared with patients who carry PKD1 mutations (35, 36). This evidence concerns the gene PKD2 and stage 5 chronic kidney disease.